These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 17877653)

  • 1. Patient satisfaction with eletriptan in the acute treatment of migraine in primary care.
    Nett RB; Tiseo PJ; Almas M; Sikes CR
    Int J Clin Pract; 2007 Oct; 61(10):1677-85. PubMed ID: 17877653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing the efficacy of eletriptan for migraine in women during menstrual and non-menstrual time periods: a pooled analysis of randomized controlled trials.
    Bhambri R; Martin VT; Abdulsattar Y; Silberstein S; Almas M; Chatterjee A; Ramos E
    Headache; 2014 Feb; 54(2):343-54. PubMed ID: 24256184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eletriptan in migraine patients reporting unsatisfactory response to rizatriptan.
    Goldstein J; Tiseo PT; Albert KS; Li C; Sikes CR
    Headache; 2006; 46(7):1142-50. PubMed ID: 16866718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial.
    Winner P; Linder SL; Lipton RB; Almas M; Parsons B; Pitman V
    Headache; 2007 Apr; 47(4):511-8. PubMed ID: 17445100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of eletriptan vs. naratriptan in the acute treatment of migraine.
    Garcia-Ramos G; MacGregor EA; Hilliard B; Bordini CA; Leston J; Hettiarachchi J
    Cephalalgia; 2003 Nov; 23(9):869-76. PubMed ID: 14616928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative sensitivity of stopwatch methodology and conventional pain assessment measures for detecting early response to triptans in migraine: results of a randomized, open-label pilot study.
    Sunshine A; Mulhern SA; Olson N; Elkind A; Almas M; Sikes C
    Clin Ther; 2006 Aug; 28(8):1107-1115. PubMed ID: 16982287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of eletriptan in migraine-related functional impairment: functional and work productivity outcomes.
    Silberstein SD; Cady RK; Sheftell FD; Almas M; Parsons B; Albert KS
    Headache; 2007 May; 47(5):673-82. PubMed ID: 17501848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome for headache and pain-free nonresponders to treatment of the first attack: a pooled post-hoc analysis of four randomized trials of eletriptan 40 mg.
    Landy SH; Tepper SJ; Schweizer E; Almas M; Ramos E
    Cephalalgia; 2014 Apr; 34(5):376-81. PubMed ID: 24265285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Satisfaction with and confidence in needle-free subcutaneous sumatriptan in patients currently treated with triptans.
    Cady RK; Aurora SK; Brandes JL; Rothrock JF; Myers JA; Fox AW; Farr SJ
    Headache; 2011 Sep; 51(8):1202-11. PubMed ID: 21812775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-life experiences in migraine therapy.
    Turcani P; Farkasova D; Marcek T; Turcani M
    Bratisl Lek Listy; 2010; 111(2):74-8. PubMed ID: 20429318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preference for rizatriptan 10-mg wafer vs. eletriptan 40-mg tablet for acute treatment of migraine.
    Láinez MJ; Evers S; Kinge E; Allais G; Allen C; Rao NA; Massaad R; Lis K
    Cephalalgia; 2006 Mar; 26(3):246-56. PubMed ID: 16472330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of eletriptan in migraineurs with persistent poor response to nonsteroidal anti-inflammatory drugs.
    Chia YC; Lim SH; Wang SJ; Cheong YM; Denaro J; Hettiarachchi J
    Headache; 2003 Oct; 43(9):984-90. PubMed ID: 14511275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perimenstrual eletriptan prevents menstrual migraine: an open-label study.
    Marcus DA; Bernstein CD; Sullivan EA; Rudy TE
    Headache; 2010 Apr; 50(4):551-62. PubMed ID: 20236337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consistency of eletriptan in treating migraine: Results of a randomized, within-patient multiple-dose study.
    Almas M; Tepper SJ; Landy S; Schweizer E; Ramos E
    Cephalalgia; 2014 Feb; 34(2):126-35. PubMed ID: 23946318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eletriptan for acute migraine.
    Smith LA; Oldman AD; McQuay HJ; Moore RA
    Cochrane Database Syst Rev; 2001; (3):CD003224. PubMed ID: 11687056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of eletriptan in acute migraine: primary care for Excedrin nonresponders.
    Diamond ML; Hettiarachchi J; Hilliard B; Sands G; Nett R
    Headache; 2004 Mar; 44(3):209-16. PubMed ID: 15012657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison.
    Diener HC; Jansen JP; Reches A; Pascual J; Pitei D; Steiner TJ;
    Eur Neurol; 2002; 47(2):99-107. PubMed ID: 11844898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eletriptan in the early treatment of acute migraine: influence of pain intensity and time of dosing.
    Brandes JL; Kudrow D; Cady R; Tiseo PJ; Sun W; Sikes CR
    Cephalalgia; 2005 Sep; 25(9):735-42. PubMed ID: 16109056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WITHDRAWN: Eletriptan for acute migraine.
    Smith LA; Oldman AD; McQuay HJ; Moore RA
    Cochrane Database Syst Rev; 2007 Jul; 2001(1):CD003224. PubMed ID: 17636718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eletriptan treatment of migraine in patients switching from barbiturate-containing analgesics: results from a multiple-attack study.
    Martin VT; Loder E; Taylor K; Almas M; Hilliard B
    Cephalalgia; 2005 Sep; 25(9):726-34. PubMed ID: 16109055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.